Come up with a name for your new list and we'll add to it:
SphynKx Therapeutics raised a round of funding on July 05, 2012. Investors include
National Institute of General Medical Sciences.
SphynKx Therapeutics is a privately held biotechnology company based in Charlottesville, VA. We are focused on discovering, developing, and commercializing novel sphingosine kinase (SphK) inhibitors f…